Unima — Revolutionizing Disease Diagnostics and Surveillance

SP Investment Fund is a California-based investment company that specializes in investment in and acquisition, development, and rehabilitation of affordable housing units across the United States. In addition to affordable housing, SP Investment Fund invests in limited partner rights and emerging technologies that embody positive social impact, such as Unima. A biotechnology company that aims to transform the diagnostic and preventative component of health care by offering a low-cost device that can diagnose infectious diseases in less than 15 minutes without dependence on lab equipment, Unima has developed a three-step process that starts with piercing a finger. Then, a drop of blood is placed onto a diagnostic paper device. Finally, a photo of the paper is taken with a smartphone app. The chimeric recombinant antibody present in the diagnostic paper generates a visual reaction that is analyzed with image processing, artificial intelligence, and machine learning. The data and analytics of the blood sample are saved and stored in a cloud server to determine any correlation with a potential disease outbreak. The retail cost of a blood test using the diagnostic paper device is approximately $1. The economic and convenience aspects of Unima’s technology will be instrumental in providing accurate diagnostics and real-time disease surveillance for 2 billion people in developing countries.
